Evidence map›Paper›PMID 42576067›Full record

ArticleNature cardiovascular research2026

Dynamic cellular programs of human cardiac allograft rejection revealed by spatial transcriptomics.

Kaushik Amancherla, Angela M Taravella Oill, Xavier Bledsoe, Arianna L Williams, Nelson Chow, Anna J Smith, Melissa A Farrow, Shilin Zhao, Quanhu Sheng, David W Bearl and 20 more

Abstract read
In one paragraph

Article in Nature cardiovascular research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Kaushik Amancherla *Vanderbilt Translational and Clinical Cardiovascular Research Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Angela M Taravella Oill *Division of Bioinnovation and Genome Sciences, The Translational Genomics Research Institute, Phoenix, AZ, USA.ORCID http://orcid.org/0000-0002-4408-7211
Xavier BledsoeVanderbilt University School of Medicine, Nashville, TN, USA.ORCID http://orcid.org/0000-0002-6091-9372
Arianna L WilliamsDivision of Bioinnovation and Genome Sciences, The Translational Genomics Research Institute, Phoenix, AZ, USA.ORCID http://orcid.org/0009-0002-2725-0221
Nelson ChowDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0009-0003-8160-8455
Anna J SmithVanderbilt University School of Medicine, Nashville, TN, USA.
Melissa A FarrowVanderbilt University School of Medicine, Nashville, TN, USA.
Shilin ZhaoDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.
Quanhu ShengDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0001-8951-9295
David W BearlDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0002-1325-4814
Alexander N PerezDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0001-5699-9501
Robert D HoffmanDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
Jonathan N MenachemDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Hasan K SiddiqiDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Douglas M BrinkleyDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0002-9511-7767
Evan D MeeDivision of Bioinnovation and Genome Sciences, The Translational Genomics Research Institute, Phoenix, AZ, USA.
Niran HadadDivision of Bioinnovation and Genome Sciences, The Translational Genomics Research Institute, Phoenix, AZ, USA.
Vineet AgrawalVanderbilt Translational and Clinical Cardiovascular Research Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
Jeffrey SchmeckpepperDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0001-9437-5871
Aniket RaliDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Stacy TsaiDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0009-0004-3566-9799
Eric Farber-EgerDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0003-0281-3796
Quinn S WellsVanderbilt Translational and Clinical Cardiovascular Research Center, Vanderbilt University School of Medicine, Nashville, TN, USA.ORCID http://orcid.org/0009-0009-4141-1520
Jane E FreedmanDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Nathan R TuckerThe State University of New York Upstate Medical University, Syracuse, NY, USA.
Jeffrey M SpragginsVanderbilt University School of Medicine, Nashville, TN, USA.
Kelly H SchlendorfDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Eric R GamazonVanderbilt University School of Medicine, Nashville, TN, USA.ORCID http://orcid.org/0000-0003-4204-8734
Nicholas BanovichDivision of Bioinnovation and Genome Sciences, The Translational Genomics Research Institute, Phoenix, AZ, USA. nbanovich@tgen.org.ORCID http://orcid.org/0000-0003-2604-3247
Ravi V ShahVanderbilt Translational and Clinical Cardiovascular Research Center, Vanderbilt University School of Medicine, Nashville, TN, USA. ravi.shah@vumc.org.ORCID http://orcid.org/0000-0002-4471-7156

Funding

Cell-Specific Transcriptional Programs in Cardiac Allograft VasculopathyK23HL166960 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kaushik Amancherla · 2024 to 2026
$556k
NHLBI NIH HHS K23 HL166960U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) K23HL166960
6 · The paper itself

Abstract

Allograft rejection following solid-organ transplantation is a major cause of graft dysfunction and mortality. Current diagnostic approaches rely on histology, which exhibits wide diagnostic variability and lacks clinically relevant molecular phenotyping. Here we leverage image-based spatial transcriptomics at subcellular resolution in longitudinal human cardiac biopsies to characterize transcriptional heterogeneity in 62 adult and pediatric heart transplant recipients during and following histologically diagnosed rejection. Across 28 cell types, we identified significant differences in abundance in immune and parenchymal cells across different classes of rejection. We observed broad overlap in transcriptional states across rejection severity and significant heterogeneity within rejection grades. Responders and nonresponders to augmented therapies had distinct transcriptomic profiles, with nonresponders exhibiting baseline T cell hyperactivation and tissue remodeling genes. We also identified cell-specific genes linked to long-term outcomes after heart transplant. These results underscore the importance of subtyping cellular states during rejection to stratify immune-cardiac interactions relevant to short- and long-term outcomes.

Indexed as

Graft RejectionHeart TransplantationMyocardiumSpatial TranscriptomicsTranscriptomeAdolescentAdultAllograftsBiopsyChildChild, PreschoolFemaleGene Expression ProfilingHumansImmunosuppressive AgentsMaleImmunosuppressive Agents

Identifiers

PMID42576067
PMCPMC13561861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.